Paragon Capital Management (Colorado)’s Pfizer PFE Stock Holding History

Paragon Capital Management (Colorado)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$701K	Sell	24,981 -273	-1%	-$7.27K	0.15%	58
2025 Q4	$629K	Buy	25,254 +648	+3%	+$16.3K	0.13%	64
2025 Q3	$627K	Sell	24,606 -352	-1%	-$8.69K	0.12%	64
2025 Q2	$605K	Buy	24,958 +7,339	+42%	+$171K	0.11%	67
2025 Q1	$446K	Hold	17,619	–	–	0.09%	80
2024 Q4	$467K	Sell	17,619 -330	-2%	-$8.95K	0.09%	68
2024 Q3	$519K	Hold	17,949	–	–	0.1%	64
2024 Q2	$502K	Sell	17,949 -1,564	-8%	-$43.1K	0.09%	62
2024 Q1	$541K	Buy	19,513 +539	+3%	+$15K	0.1%	63
2023 Q4	$546K	Buy	18,974 +1,000	+6%	+$30.2K	0.11%	58
2023 Q3	$596K	Hold	17,974	–	–	0.13%	54
2023 Q2	$659K	Sell	17,974 -1,750	-9%	-$68.1K	0.14%	52
2023 Q1	$805K	Hold	19,724	–	–	0.18%	45
2022 Q4	$1.01M	Hold	19,724	–	–	0.27%	33
2022 Q3	$863K	Sell	19,724 -2,856	-13%	-$139K	0.25%	35
2022 Q2	$1.18M	Sell	22,580 -5,277	-19%	-$269K	0.33%	33
2022 Q1	$1.44M	Buy	27,857 +176	+0.6%	+$9.13K	0.27%	33
2021 Q4	$1.64M	Sell	27,681 -762	-3%	-$37.8K	0.26%	32
2021 Q3	$1.22M	Sell	28,443 -1,805	-6%	-$80K	0.21%	35
2021 Q2	$1.19M	Buy	30,248 +4,802	+19%	+$187K	0.55%	24
2021 Q1	$922K	Sell	25,446 -1,151	-4%	-$40.9K	0.48%	27
2020 Q4	$979K	Sell	26,597 -1,436	-5%	-$52.7K	0.54%	25
2020 Q3	$976K	Buy	+28,033	New	+$983K	0.53%	24
2020 Q1	–	Sell	-32,138	Closed	-$1.2M	–	145
2019 Q4	$1.2M	Hold	32,138	–	–	0.63%	19
2019 Q3	$1.1M	Sell	32,138 -1,534	-5%	-$55.8K	0.61%	19
2019 Q2	$1.38M	Sell	33,672 -1,423	-4%	-$56.5K	0.79%	15
2019 Q1	$1.41M	Hold	35,095	–	–	0.86%	14
2018 Q4	$1.45M	Sell	35,095 -415	-1%	-$17.2K	0.7%	15
2018 Q3	$1.49M	Buy	35,510 +270	+0.8%	+$10.4K	1.27%	13
2018 Q2	$1.21M	Sell	35,240 -419	-1%	-$14.3K	1.08%	17
2018 Q1	$1.2M	Buy	+35,659	New	+$1.23M	0.53%	25
2017 Q4	–	Sell	-46,246	Closed	-$1.57M	–	211
2017 Q3	$1.57M	Buy	46,246 +1,676	+4%	+$53.9K	0.6%	25
2017 Q2	$1.42M	Buy	44,570 +13,081	+42%	+$413K	0.65%	22
2017 Q1	$1.02M	Buy	+31,489	New	+$993K	0.46%	27
2016 Q3	$753K	Sell	23,444 -2,846	-11%	-$95.2K	0.41%	26
2016 Q2	$878K	Buy	26,290 +527	+2%	+$16.8K	0.48%	25
2016 Q1	$724K	Hold	25,763	–	–	0.44%	28
2015 Q4	$789K	Buy	25,763 +527	+2%	+$16.6K	0.49%	25
2015 Q3	$752K	Buy	25,236 +3,459	+16%	+$111K	0.46%	28
2015 Q2	$693K	Hold	21,777	–	–	0.44%	29
2015 Q1	$719K	Sell	21,777 -316	-1%	-$10K	0.47%	25
2014 Q4	$653K	Sell	22,093 -342	-2%	-$9.81K	0.46%	28
2014 Q3	$629K	Hold	22,435	–	–	0.44%	28
2014 Q2	$632K	Hold	22,435	–	–	0.43%	30
2014 Q1	$684K	Hold	22,435	–	–	0.51%	26
2013 Q4	$652K	Hold	22,435	–	–	0.48%	27
2013 Q3	$611K	Sell	22,435 -1,054	-4%	-$28.7K	0.48%	24
2013 Q2	$624K	Buy	+23,489	New	+$649K	0.5%	25

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Paragon Capital Management (Colorado)'s PFE Position: Q1 2026 in Review

Paragon Capital Management (Colorado) reduced its Pfizer (PFE) stake by 1.1% in Q1 2026, selling an estimated $7.27K and leaving 24,981 shares worth $701K. The position accounts for 0.15% of the portfolio, ranked #58.

Paragon Capital Management (Colorado) first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.64M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Paragon Capital Management (Colorado) held 24,981 shares of Pfizer worth $701K as of Q1 2026.
Paragon Capital Management (Colorado) sold 273 Pfizer shares in Q1 2026, an estimated $7.27K.
Pfizer made up 0.15% of Paragon Capital Management (Colorado)'s portfolio in Q1 2026, its #58 holding.
Paragon Capital Management (Colorado) first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
Paragon Capital Management (Colorado)'s Pfizer position peaked at $1.64M in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q1 2026, filed 15 Apr 2026.